WuXi AppTec (OTCMKTS:WUXAY) Hits New 52-Week High – What’s Next?

WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY)’s share price reached a new 52-week high during mid-day trading on Thursday . The company traded as high as $21.00 and last traded at $21.00, with a volume of 809 shares. The stock had previously closed at $20.21.

Wall Street Analyst Weigh In

Separately, Zacks Research raised shares of WuXi AppTec to a “hold” rating in a research note on Monday, April 13th. One investment analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy”.

WuXi AppTec Price Performance

The business has a 50-day moving average price of $17.46 and a 200-day moving average price of $15.84.

WuXi AppTec (OTCMKTS:WUXAY) last announced its quarterly earnings data on Monday, April 27th. The company reported $0.23 EPS for the quarter, topping analysts’ consensus estimates of $0.18 by $0.05. The company had revenue of $1.82 billion for the quarter, compared to analysts’ expectations of $1.59 billion.

WuXi AppTec Company Profile

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.